002826 易明医药
已收盘 04-30 15:00:00
资讯
新帖
简况
易明医药:4月28日高管许可减持股份合计5300股
证券之星 · 04-29
易明医药:4月28日高管许可减持股份合计5300股
易明医药收盘上涨1.05%,滚动市盈率54.63倍,总市值20.12亿元
金融界 · 04-29
易明医药收盘上涨1.05%,滚动市盈率54.63倍,总市值20.12亿元
图解易明医药年报:第四季度单季净利润同比增148.34%
证券之星 · 04-24
图解易明医药年报:第四季度单季净利润同比增148.34%
易明医药:截至2025年4月10日,本公司股东数为16,223户
证券之星 · 04-18
易明医药:截至2025年4月10日,本公司股东数为16,223户
易明医药(002826)3月10日股东户数1.66万户,较上期增加2.41%
证券之星 · 03-11
易明医药(002826)3月10日股东户数1.66万户,较上期增加2.41%
3月9日增减持汇总:冰轮环境增持 易明医药等4股减持(表)
新浪证券 · 03-09
3月9日增减持汇总:冰轮环境增持 易明医药等4股减持(表)
易明医药最新公告:董事、股东拟合计减持不超2.04%公司股份
证券之星 · 03-09
易明医药最新公告:董事、股东拟合计减持不超2.04%公司股份
易明医药(002826.SZ)部分股东、董事拟合计减持不超2.04%股份
智通财经 · 03-09
易明医药(002826.SZ)部分股东、董事拟合计减持不超2.04%股份
【易明医药:董事、股东拟合计减持不超2.04%公司股份】易明医药公告,公司董事、持股5%以上股东周战计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过359万股(不超过公司总股本的1.8828%);董事许可计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过30万股(不超过公司总股本的0.1573%)。
金融界 · 03-09
【易明医药:董事、股东拟合计减持不超2.04%公司股份】易明医药公告,公司董事、持股5%以上股东周战计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过359万股(不超过公司总股本的1.8828%);董事许可计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过30万股(不超过公司总股本的0.1573%)。
易明医药(002826)2月28日股东户数1.62万户,较上期增加1.46%
证券之星 · 03-04
易明医药(002826)2月28日股东户数1.62万户,较上期增加1.46%
易明医药:截至2025年2月28日,本公司股东人数为16,231户
证券之星 · 03-04
易明医药:截至2025年2月28日,本公司股东人数为16,231户
易明医药:我司医药生产未用AI技术
证券之星 · 02-17
易明医药:我司医药生产未用AI技术
易明医药:蒙脱石散(贝易平®)可以吸附肠道黏膜上一部分的病毒、细菌及其产生的毒素等
证券之星 · 02-17
易明医药:蒙脱石散(贝易平®)可以吸附肠道黏膜上一部分的病毒、细菌及其产生的毒素等
易明医药(002826)1月27日股东户数1.53万户,较上期减少3.55%
证券之星 · 02-10
易明医药(002826)1月27日股东户数1.53万户,较上期减少3.55%
易明医药收盘上涨3.08%,滚动市盈率65.13倍,总市值21.70亿元
金融界 · 02-05
易明医药收盘上涨3.08%,滚动市盈率65.13倍,总市值21.70亿元
易明医药:公司无原研药
互动易 · 02-05
易明医药:公司无原研药
加载更多
公司概况
公司名称:
西藏易明西雅医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2016-12-09
主营业务:
西藏易明西雅医药科技股份有限公司主要从事化学药(原料药和制剂)以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点,全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》(2022年版),部分产品列入国家基本药物目录,具备全国独家、首家仿制等优势,在细分市场上均具有较强的竞争力和较好的成长空间。
发行价格:
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":10.62,"timestamp":1745996598000,"preClose":10.55,"halted":0,"volume":2906700,"delay":0,"changeRate":0.0066,"floatShares":173000000,"shares":191000000,"eps":0.1932,"marketStatus":"已收盘","change":0.07,"latestTime":"04-30 15:00:00","open":10.65,"high":10.74,"low":10.56,"amount":31014100,"amplitude":0.0171,"askPrice":10.62,"askSize":18,"bidPrice":10.6,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.1932,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":10.55,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":11.61,"lowLimit":9.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":2.64,"roa":"--","peRate":54.968944,"roe":"2.51%","epsLYR":0.25,"committee":0.034934,"marketValue":2025000000,"turnoverRate":0.0168,"status":0,"floatMarketCap":1834000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2531310797","title":"易明医药:4月28日高管许可减持股份合计5300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531310797","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531310797?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:04","pubTimestamp":1745931864,"startTime":"0","endTime":"0","summary":"证券之星消息,根据4月29日市场公开信息、上市公司公告及交易所披露数据整理,易明医药(002826)最新董监高及相关人员股份变动情况:2025年4月28日公司董事许可共减持公司股份5300.0股,占公司总股本为0.0028%。变动期间公司股价下跌1.04%,4月28日当日收盘报10.44元。易明医药近半年内的董监高及核心技术人员增减持详情如下:易明医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900041112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2531272753","title":"易明医药收盘上涨1.05%,滚动市盈率54.63倍,总市值20.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531272753","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531272753?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:56","pubTimestamp":1745916976,"startTime":"0","endTime":"0","summary":"4月29日,易明医药今日收盘10.55元,上涨1.05%,滚动市盈率PE达到54.63倍,总市值20.12亿元。从行业市盈率排名来看,公司所处的中药行业市盈率平均35.88倍,行业中值24.49倍,易明医药排名第56位。股东方面,截至2025年4月18日,易明医药股东户数16005户,较上次减少218户,户均持股市值35.28万元,户均持股数量2.76万股。最新一期业绩显示,2025年一季报,公司实现营业收入1.49亿元,同比-7.41%;净利润1879.39万元,同比-32.64%,销售毛利率79.87%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/29165649999129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0056","002826","BK0033"],"gpt_icon":0},{"id":"2530496388","title":"图解易明医药年报:第四季度单季净利润同比增148.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530496388?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:26","pubTimestamp":1745515599,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药2024年年报显示,公司主营收入6.52亿元,同比下降2.27%;归母净利润4592.88万元,同比上升198.5%;扣非净利润1844.67万元,同比上升1579.33%;其中2024年第四季度,公司单季度主营收入1.39亿元,同比上升8.0%;单季度归母净利润410.94万元,同比上升148.34%;单季度扣非净利润210.82万元,同比上升121.46%;负债率19.52%,投资收益351.36万元,财务费用-116.56万元,毛利率68.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2528037545","title":"易明医药:截至2025年4月10日,本公司股东数为16,223户","url":"https://stock-news.laohu8.com/highlight/detail?id=2528037545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528037545?lang=zh_cn&edition=full","pubTime":"2025-04-18 16:24","pubTimestamp":1744964654,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)04月18日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截止到4月10日公司股东人数是多少?易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年4月10日,本公司股东数为16,223户。感谢关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041800024169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0},{"id":"2518797050","title":"易明医药(002826)3月10日股东户数1.66万户,较上期增加2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518797050?lang=zh_cn&edition=full","pubTime":"2025-03-11 17:14","pubTimestamp":1741684470,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2025年3月10日公司股东户数为1.66万户,较2月28日增加391.0户,增幅为2.41%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至3月10日,化学制药行业平均股东户数为3.08万户。从股价来看,2025年2月28日至2025年3月10日,易明医药区间涨幅为2.55%,在此期间股东户数增加391.0户,增幅为2.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100030205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2518628325","title":"3月9日增减持汇总:冰轮环境增持 易明医药等4股减持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628325","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518628325?lang=zh_cn&edition=full","pubTime":"2025-03-09 21:54","pubTimestamp":1741528440,"startTime":"0","endTime":"0","summary":"据统计,3月9日,冰轮环境披露增持情况。包括易明医药、康鹏科技、长春一东、光威复材在内的4家A股上市公司披露减持情况。\n\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-09/doc-inepakse1483287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002826","BK0056","BK0259","BK0151","BK0033","BK0188","BK0239","000811","BK0117","BK0175"],"gpt_icon":0},{"id":"2518409111","title":"易明医药最新公告:董事、股东拟合计减持不超2.04%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2518409111","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518409111?lang=zh_cn&edition=full","pubTime":"2025-03-09 17:30","pubTimestamp":1741512655,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)公告称,公司董事、持股5%以上股东周战计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过359万股(不超过公司总股本的1.8828%);董事许可计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过30万股(不超过公司总股本的0.1573%)。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030900002882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2518640962","title":"易明医药(002826.SZ)部分股东、董事拟合计减持不超2.04%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2518640962","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518640962?lang=zh_cn&edition=full","pubTime":"2025-03-09 17:22","pubTimestamp":1741512175,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)公告,公司董事、持股5%以上股东周战,董事许可拟合计减持公司股份不超过389万股,占公司总股本比例2.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2518409956","title":"【易明医药:董事、股东拟合计减持不超2.04%公司股份】易明医药公告,公司董事、持股5%以上股东周战计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过359万股(不超过公司总股本的1.8828%);董事许可计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过30万股(不超过公司总股本的0.1573%)。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518409956","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518409956?lang=zh_cn&edition=full","pubTime":"2025-03-09 17:19","pubTimestamp":1741511958,"startTime":"0","endTime":"0","summary":"易明医药公告,公司董事、持股5%以上股东周战计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过359万股(不超过公司总股本的1.8828%);董事许可计划15个交易日后的3个月内,以集中竞价方式或大宗交易方式减持公司股份不超过30万股(不超过公司总股本的0.1573%)。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/09171948614882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0033","002826","BK0239","BK0056"],"gpt_icon":0},{"id":"2516006628","title":"易明医药(002826)2月28日股东户数1.62万户,较上期增加1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516006628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516006628?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:22","pubTimestamp":1741080142,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2025年2月28日公司股东户数为1.62万户,较2月20日增加233.0户,增幅为1.46%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至2月28日,化学制药行业平均股东户数为3.09万户。从股价来看,2025年2月20日至2025年2月28日,易明医药区间跌幅为7.12%,在此期间股东户数增加233.0户,增幅为1.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400029693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0239","BK0033"],"gpt_icon":0},{"id":"2516990536","title":"易明医药:截至2025年2月28日,本公司股东人数为16,231户","url":"https://stock-news.laohu8.com/highlight/detail?id=2516990536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516990536?lang=zh_cn&edition=full","pubTime":"2025-03-04 09:30","pubTimestamp":1741051842,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药03月03日在投资者关系平台上答复投资者关心的问题。请问贵公司2025年2月28日A股股东人数是多少?谢谢易明医药董秘:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年2月28日,本公司股东人数为16,231户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400009039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2512947853","title":"易明医药:我司医药生产未用AI技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2512947853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512947853?lang=zh_cn&edition=full","pubTime":"2025-02-17 21:00","pubTimestamp":1739797232,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)02月17日在投资者关系平台上答复投资者关心的问题。投资者:请问ai技术有没有应用于医药生产易明医药董秘:尊敬的投资者,您好。我司医药生产未用AI技术,感谢关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700031482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK1574","BK1161","159938","09939","BK1515","BK0056","BK0239"],"gpt_icon":0},{"id":"2512914534","title":"易明医药:蒙脱石散(贝易平®)可以吸附肠道黏膜上一部分的病毒、细菌及其产生的毒素等","url":"https://stock-news.laohu8.com/highlight/detail?id=2512914534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512914534?lang=zh_cn&edition=full","pubTime":"2025-02-17 16:30","pubTimestamp":1739781038,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)02月17日在投资者关系平台上答复投资者关心的问题。投资者:近日,广东深圳市疾控中心发布消息,2月12日至18日,深圳诺如病毒感染性腹泻风险等级由低调整为“中”。请问贵司产品能应对诺如病毒吧,易明医药董秘:尊敬的投资者,您好。我司蒙脱石散(贝易平®)可以吸附肠道黏膜上一部分的病毒、细菌及其产生的毒素等,使其失去致病作用,从而缓解腹泻症状。具体用药建议请遵医嘱。感谢关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700017719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"gpt_icon":0},{"id":"2510836108","title":"易明医药(002826)1月27日股东户数1.53万户,较上期减少3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510836108","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510836108?lang=zh_cn&edition=full","pubTime":"2025-02-10 17:10","pubTimestamp":1739178606,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2025年1月27日公司股东户数为1.53万户,较1月20日减少561.0户,减幅为3.55%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至1月27日,化学制药行业平均股东户数为3.08万户。从股价来看,2025年1月20日至2025年1月27日,易明医药区间跌幅为2.3%,在此期间股东户数减少561.0户,减幅为3.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000021826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2509964479","title":"易明医药收盘上涨3.08%,滚动市盈率65.13倍,总市值21.70亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509964479","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509964479?lang=zh_cn&edition=full","pubTime":"2025-02-05 16:26","pubTimestamp":1738744001,"startTime":"0","endTime":"0","summary":"2月5日,易明医药今日收盘11.38元,上涨3.08%,滚动市盈率PE达到65.13倍,创26天以来新低,总市值21.70亿元。从行业市盈率排名来看,公司所处的中药行业市盈率平均38.79倍,行业中值27.19倍,易明医药排名第60位。截至2024年三季报,共有1家机构持仓易明医药,其中基金1家,合计持股数4.98万股,持股市值0.01亿元。最新一期业绩显示,2024年三季报,公司实现营业收入5.13亿元,同比-4.73%;净利润4181.94万元,同比75.06%,销售毛利率67.05%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/05162647957848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0033","BK0239","BK0056","002826"],"gpt_icon":0},{"id":"2509267074","title":"易明医药:公司无原研药","url":"https://stock-news.laohu8.com/highlight/detail?id=2509267074","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509267074?lang=zh_cn&edition=full","pubTime":"2025-02-05 11:33","pubTimestamp":1738726380,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 有投资者向易明医药提问, 请问贵司有原研药吗?公司回答表示,尊敬的投资者,您好。公司无原研药,感谢关注。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-05/doc-ineimcyh2159438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746249602839,"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":-0.0139},{"period":"3month","weight":-0.038},{"period":"6month","weight":0.1531},{"period":"1year","weight":0.1959},{"period":"ytd","weight":0.0251}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16005人(较上一季度减少1.34%)","perCapita":"10791股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司主要从事化学药(原料药和制剂)以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点,全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》(2022年版),部分产品列入国家基本药物目录,具备全国独家、首家仿制等优势,在细分市场上均具有较强的竞争力和较好的成长空间。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}